Guangzhou Baiyunshan Pharmaceutical Holdings Company (HK:0874) has released an update.
Guangzhou Baiyunshan Pharmaceutical Holdings Company is set to hold its first extraordinary general meeting of 2025 on January 21, where shareholders will have the opportunity to vote both on-site and online. Key resolutions include electing Mr. Li Xiaojun as an executive director and Ms. Liu Lan as a shareholder representative supervisor. The meeting highlights the company’s commitment to engaging its shareholders through accessible voting methods.
For further insights into HK:0874 stock, check out TipRanks’ Stock Analysis page.